Matches in SemOpenAlex for { <https://semopenalex.org/work/W2223875255> ?p ?o ?g. }
- W2223875255 endingPage "798" @default.
- W2223875255 startingPage "793" @default.
- W2223875255 abstract "Ibrutinib, a recently approved inhibitor of Bruton’s tyrosine kinase (BTK), has shown great efficacy in patients with high-risk CLL. Nevertheless, there are few data regarding its use in patients who relapsed after allogeneic stem cell transplantation (alloSCT). We report clinical data from five CLL patients treated with ibrutinib for relapse after first or even second allogeneic transplantation. Additionally, we performed analyses on cytokine levels and direct measuring of CD4 Th1 and CD4 Th2 cells to evaluate possible clinically relevant immunomodulatory effects of ibrutinib. All patients achieved partial responses including one minimal residual disease (MRD)-negative remission. Within 1 year of follow-up, no relapse was observed. One patient died of severe pneumonia while on ibrutinib treatment. Beside this, no unexpected adverse events were observed. Flow cytometry and analyses of T cell-mediated cytokine levels (IL10 and TNFα) did not reveal substantial changes in T-cell distribution in favor of a CD4 Th1 T-cell shift in our patients. No acute exacerbation of GvHD was reported. In conclusion, these results support further evaluation of ibrutinib in CLL patients relapsing after alloSCT." @default.
- W2223875255 created "2016-06-24" @default.
- W2223875255 creator A5004741011 @default.
- W2223875255 creator A5013302108 @default.
- W2223875255 creator A5018230264 @default.
- W2223875255 creator A5021219695 @default.
- W2223875255 creator A5021974658 @default.
- W2223875255 creator A5026089731 @default.
- W2223875255 creator A5026849709 @default.
- W2223875255 creator A5037944783 @default.
- W2223875255 creator A5056556114 @default.
- W2223875255 creator A5071271927 @default.
- W2223875255 creator A5071651804 @default.
- W2223875255 creator A5073616355 @default.
- W2223875255 creator A5079124367 @default.
- W2223875255 creator A5082379829 @default.
- W2223875255 date "2016-01-11" @default.
- W2223875255 modified "2023-10-07" @default.
- W2223875255 title "Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation" @default.
- W2223875255 cites W1551467549 @default.
- W2223875255 cites W187751294 @default.
- W2223875255 cites W1935657689 @default.
- W2223875255 cites W1970312642 @default.
- W2223875255 cites W2000476802 @default.
- W2223875255 cites W2003779377 @default.
- W2223875255 cites W2011950935 @default.
- W2223875255 cites W2015672274 @default.
- W2223875255 cites W2029503621 @default.
- W2223875255 cites W2040040334 @default.
- W2223875255 cites W2049287587 @default.
- W2223875255 cites W2054709506 @default.
- W2223875255 cites W2069766931 @default.
- W2223875255 cites W2070556665 @default.
- W2223875255 cites W2071549499 @default.
- W2223875255 cites W2075875145 @default.
- W2223875255 cites W2089103836 @default.
- W2223875255 cites W2096644943 @default.
- W2223875255 cites W2107307057 @default.
- W2223875255 cites W2108206643 @default.
- W2223875255 cites W2116249739 @default.
- W2223875255 cites W2128213592 @default.
- W2223875255 cites W2137858990 @default.
- W2223875255 cites W2142099365 @default.
- W2223875255 cites W2154360891 @default.
- W2223875255 cites W2160300557 @default.
- W2223875255 cites W2163847512 @default.
- W2223875255 cites W2166237040 @default.
- W2223875255 cites W2168116220 @default.
- W2223875255 cites W2483374376 @default.
- W2223875255 cites W2558323997 @default.
- W2223875255 doi "https://doi.org/10.1038/bmt.2015.339" @default.
- W2223875255 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26752141" @default.
- W2223875255 hasPublicationYear "2016" @default.
- W2223875255 type Work @default.
- W2223875255 sameAs 2223875255 @default.
- W2223875255 citedByCount "25" @default.
- W2223875255 countsByYear W22238752552016 @default.
- W2223875255 countsByYear W22238752552017 @default.
- W2223875255 countsByYear W22238752552018 @default.
- W2223875255 countsByYear W22238752552019 @default.
- W2223875255 countsByYear W22238752552020 @default.
- W2223875255 countsByYear W22238752552021 @default.
- W2223875255 countsByYear W22238752552023 @default.
- W2223875255 crossrefType "journal-article" @default.
- W2223875255 hasAuthorship W2223875255A5004741011 @default.
- W2223875255 hasAuthorship W2223875255A5013302108 @default.
- W2223875255 hasAuthorship W2223875255A5018230264 @default.
- W2223875255 hasAuthorship W2223875255A5021219695 @default.
- W2223875255 hasAuthorship W2223875255A5021974658 @default.
- W2223875255 hasAuthorship W2223875255A5026089731 @default.
- W2223875255 hasAuthorship W2223875255A5026849709 @default.
- W2223875255 hasAuthorship W2223875255A5037944783 @default.
- W2223875255 hasAuthorship W2223875255A5056556114 @default.
- W2223875255 hasAuthorship W2223875255A5071271927 @default.
- W2223875255 hasAuthorship W2223875255A5071651804 @default.
- W2223875255 hasAuthorship W2223875255A5073616355 @default.
- W2223875255 hasAuthorship W2223875255A5079124367 @default.
- W2223875255 hasAuthorship W2223875255A5082379829 @default.
- W2223875255 hasBestOaLocation W22238752551 @default.
- W2223875255 hasConcept C126322002 @default.
- W2223875255 hasConcept C143998085 @default.
- W2223875255 hasConcept C170493617 @default.
- W2223875255 hasConcept C203014093 @default.
- W2223875255 hasConcept C2777938653 @default.
- W2223875255 hasConcept C2778461978 @default.
- W2223875255 hasConcept C2779823535 @default.
- W2223875255 hasConcept C2779878957 @default.
- W2223875255 hasConcept C28328180 @default.
- W2223875255 hasConcept C2911091166 @default.
- W2223875255 hasConcept C42362537 @default.
- W2223875255 hasConcept C54355233 @default.
- W2223875255 hasConcept C71924100 @default.
- W2223875255 hasConcept C86803240 @default.
- W2223875255 hasConcept C90059517 @default.
- W2223875255 hasConceptScore W2223875255C126322002 @default.
- W2223875255 hasConceptScore W2223875255C143998085 @default.
- W2223875255 hasConceptScore W2223875255C170493617 @default.
- W2223875255 hasConceptScore W2223875255C203014093 @default.